News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
New “100 Days of Innovation” Blueprint Outlines…
As Congress and the new President lay out their aggressive “100 Day Plans,” The Biotechnology Innovation Organization (BIO) today released a new blueprint highlighting goals to strengthen America’s innovation ecosystem, end the COVID-19 pandemic,…
New Criteria Set for Political Contributions from…
The Biotechnology Innovation Organization announced today that it will resume political giving under new criteria for political leaders seeking campaign assistance. Shortly after the violent demonstration three weeks ago at the US Capitol BIO…
BIO Welcomes U.S. Involvement in COVAX, ACT…
The Biden administration just announced its intent for the United States to join the COVAX vaccine facility, which aims to deliver COVID-19 vaccines to poor and under-developed countries. Dr. Michelle McMurry-Heath, president and CEO of the…
Letters, Testimony, & Comments
BIO Letter to Biden Administration on Climate…
On behalf of the Biotechnology Innovation Organization (BIO), the nearly 1000 companies, universities, and biotech organizations we represent comprised of millions of scientists, researchers and entrepreneurs, congratulations on your historic…
BIO Comments on FDA’s Public Workshop on…
On Wednesday, December 23rd, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s October 2020 public workshop titled, “New Drugs Regulatory Program Modernization: Implementation of the Integrated Assessment of Marketing…
BIO Submits Comments on Final EPA PIP rule
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on proposed revisions to regulations related to the oversight of certain plant…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
Biden and Harris
January 22, 2021
This week marked the beginning of a new era in U.S. politics with the inauguration of President Joe Biden and Vice President Kamala Harris. In his inauguration speech, President Biden made it clear that confronting…
The hunger pandemic biotechnology
January 13, 2021
Science experts have been sounding the alarm since March when lockdowns started, that this pandemic is a drill for the impending climate change pandemic.  “Many organizations have warned that COVID-19 is only a…
Placeholder Image
January 12, 2021
In the wake of the violent riot at the U.S. Capitol last week, Biotechnology Innovation Organization (BIO) President and CEO Dr. Michelle McMurry-Heath condemned the attack and announced that all political donations by…